First Hawaiian Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

First Hawaiian Bank’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-26,540	Closed	-$446K	–	826
2023 Q4	$446K	Sell	26,540 -4,630	-15%	-$63.3K	0.01%	620
2023 Q3	$364K	Sell	31,170 -690	-2%	-$9.23K	0.01%	657
2023 Q2	$428K	Sell	31,860 -4,380	-12%	-$63K	0.01%	646
2023 Q1	$601K	Buy	36,240 +1,000	+3%	+$16.5K	0.02%	531
2022 Q4	$655K	Sell	35,240 -16,140	-31%	-$249K	0.02%	477
2022 Q3	$659K	Hold	51,380	–	–	0.03%	441
2022 Q2	$360K	Hold	51,380	–	–	0.01%	659
2022 Q1	$426K	Buy	+51,380	New	+$363K	0.01%	665

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Hawaiian Bank's CPRX Position: Q1 2024 in Review

First Hawaiian Bank sold out of Catalyst Pharmaceutical (CPRX) in Q1 2024, closing a stake of 26,540 shares — an estimated $446K sold.

First Hawaiian Bank first reported a position in CPRX in Q1 2022 and held it in 8 quarters. The position peaked at $659K in Q3 2022. 269 funds tracked by Wall St. Rank hold CPRX as of Q1 2024.

First Hawaiian Bank reported no remaining Catalyst Pharmaceutical position as of Q1 2024 after selling out during the quarter.
First Hawaiian Bank sold 26,540 Catalyst Pharmaceutical shares in Q1 2024, an estimated $446K.
First Hawaiian Bank first reported a position in Catalyst Pharmaceutical in Q1 2022 and held it in 8 quarters.
First Hawaiian Bank's Catalyst Pharmaceutical position peaked at $659K in Q3 2022.
269 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2024.

Based on First Hawaiian Bank's 13F filing for Q1 2024, filed 5 Apr 2024.